“New year, New Me!” – Wegovy
On December 22, 2025, Novo Nordisk shocked the world with breaking news: Wegovy (semaglutide) was FDA-approved in an oral formulation at a dosage of 25mg for weight loss management. Indeed, semaglutide has long existed in an oral formulation as Rybelsus (an FDA approved medication for Type 2 Diabetes and Cardiovascular Risk Reduction dose in 7mg…